gene regulation ͉ hydroxylation ͉ signal transduction R educed oxygen levels (hypoxia) lead to a set of cellular adaptations, including increased angiogenesis and erythropoiesis and a switch to glycolytic metabolism. The cellular machinery that senses hypoxia is composed of several proteins. A critical component is the transcription factor hypoxiainducible factor 1␣ (HIF-1␣) (1). The level and activity of HIF-1␣ are controlled by oxygen-dependent prolyl (PHD) and asparaginyl factor-inhibiting HIF-1␣ (FIH-1)] hydroxylases. PHDs hydroxylate two proline residues in the degradation domain of HIF-1␣ in normoxia, which makes HIF-1␣ a substrate for the von Hippel-Lindau E3 ubiquitin ligase and proteasomal degradation. After stabilization in hypoxia, HIF-1␣ interacts with aryl hydrocarbon receptor nuclear translocator (ARNT) to bind to hypoxia response elements (HREs)
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educed oxygen levels (hypoxia) lead to a set of cellular adaptations, including increased angiogenesis and erythropoiesis and a switch to glycolytic metabolism. The cellular machinery that senses hypoxia is composed of several proteins. A critical component is the transcription factor hypoxiainducible factor 1␣ (HIF-1␣) (1) . The level and activity of HIF-1␣ are controlled by oxygen-dependent prolyl (PHD) and asparaginyl factor-inhibiting HIF-1␣ (FIH-1)] hydroxylases. PHDs hydroxylate two proline residues in the degradation domain of HIF-1␣ in normoxia, which makes HIF-1␣ a substrate for the von Hippel-Lindau E3 ubiquitin ligase and proteasomal degradation. After stabilization in hypoxia, HIF-1␣ interacts with aryl hydrocarbon receptor nuclear translocator (ARNT) to bind to hypoxia response elements (HREs) and activate target genes (1) . FIH-1, in contrast, was originally found to be a negative regulator of HIF-1␣ (2) and was later shown to be an asparaginyl hydroxylase, capable of hydroxylating N 803 in the C-terminal activation domain (CAD) of human HIF-1␣ (3, 4) . This hydroxylation, which is more prevalent in normoxia, correlates with repression of HIF-1␣ function (5) .
In addition to this ''canonical'' hypoxic signaling mechanism, certain aspects of the hypoxic response, for example, in the control of stem cell differentiation, require integration with the Notch pathway (6, 7) . In Notch signaling, the Notch transmembrane receptor (Notch 1-Notch 4 in vertebrates) is activated by a family of membrane-bound ligands (DSL, including Delta-like and Jagged). Interaction with ligand leads to two consecutive cleavages, eventually liberating the Notch intracellular domain (ICD) from the plasma membrane. Notch ICD then enters the nucleus, where it interacts with the DNA-binding protein CSL (8) . Notch ICD displaces corepressors from CSL, recruits a transcriptional activation complex, including Mastermind (MAML1) and p300/CBP, and it may also in some situations control the recruitment of CSL to its corresponding binding sites in Notch-responsive promoters (9) . Notch signaling leads to transcriptional activation of immediate target genes such as Hes and Herp/Hey (8) .
We observed that hypoxia promotes the undifferentiated cell state in myogenic and neural progenitors in a Notch-dependent manner. At the molecular level, HIF-1␣ interacts with Notch 1 ICD and is recruited to a Notch-responsive promoter under conditions of active Notch signaling in hypoxia (6) . In addition to hypoxia-induced elevation of the Notch downstream response, a converse Notch-mediated potentiation of the hypoxic downstream response was noted, i.e., Notch signaling augmented hypoxia-induced expression of a bona fide HIF-1␣-inducible gene, PGK1, and the recruitment of HIF-1␣ to its promoter (6) . Because Notch ICD could not be detected at the PGK1 promoter, the action of Notch ICD may be more indirect, indicating that additional molecular mechanisms operate in the integration between Notch and hypoxia signaling. In this work, we have evaluated a possible role of FIH-1 in cross-coupling between the Notch and HIF pathways. Our data show that FIH-1 hydroxylates Notch ICD at two asparagine residues. Furthermore, Notch ICD potentiates recruitment of HIF-1␣ to HIF target promoters. The fact that Notch ICD has a higher affinity than HIF-1␣ for FIH-1 suggests that the observed Notch-mediated derepression of HIF-1␣ function, at least in part, is caused by ICD sequestering FIH-1 away from HIF-1␣.
for FIH-1-dependent hydroxylation in a 2-oxo-glutarate decarboxylation assay. Full-length mNotch 1 ICD and a shorter form spanning the seven ankyrin repeats, ANK 1-7 (Fig. 1A) , displayed robust activity in the in vitro hydroxylation assay, whereas a truncated version containing the RAM domain alone did not (Fig. 1B) . Mass spectrometry using a tandem instrument comprising linear and orbital traps (LTQ-Orbitrap) revealed FIH-1-dependent hydroxylation on a tryptic peptide encompassing residues 1937-1952 [supporting information (SI) Fig. 6A ]. Data from tandem mass spectrometry (MS/MS) and MALDI-TOF/ TOF MS/MS identified the addition of an oxygen atom uniquely in FIH-1-treated samples to hydroxylation on N 1945 . In addition, a lower level of hydroxylation was detected in a tryptic peptide encompassing residues 1995-2019 at N 2012 (SI Fig. 6B ).
We next addressed whether hydroxylation occurred in a cellular context. ANK 1-7 was expressed in 293T cells constitutively overexpressing FIH-1 in the presence or absence of the FIH-1 inhibitor dimethyloxalylglycine (DMOG). MALDI-TOF/ TOF-MS revealed a similar pattern of modifications as observed in vitro both under hypoxic and normoxic conditions. Exposure to DMOG essentially abolished formation of the peptides corresponding to hydroxylation of N 1945 and N 2012 (SI Fig. 6 C and  D) . These results demonstrate that ANK 1-7 is hydroxylated at both positions N 1945 and N 2012 within mammalian cells. To corroborate the MS/MS data, wild-type and Asn mutant forms of ANK 1-7 were analyzed for interaction with FIH-1 and for in vitro hydroxylation. Both the wild-type and mutant constructs interacted with FIH-1 (SI Fig. 7A ). The wild-type and N2012A constructs showed potent FIH-1-dependent decarboxylation activity, whereas N1945A was considerably reduced. In the case of N1945A/N2012A, activity was abolished, indicating that N 1945 and N 2012 are likely to be the only two sites of FIH-1-dependent hydroxylation within the complete ankyrin repeat domain and that N 1945 is hydroxylated more efficiently by FIH-1 than N 2012 (Fig. 1C) . Notably, N 1945 and N 2012 in Notch 1 are conserved in all Notch 1 orthologs (SI Fig. 8 ) and in mammalian Notch 2, 3, and 4, with the exception of site 2 (N 2012 ), which is a glycine residue in Notch 4. We tested whether the other Notch paralogs could also be hydroxylated by FIH-1. Trx-H 6 fusion proteins corresponding to ANK 1-7 repeats from mNotch 2, 3, and 4 (mN2-4) were expressed, purified, and analyzed by the in vitro hydroxylation assay. mN2 ANK 1-7 and mN3 ANK 1-7 gave similar FIH-1-dependent activity to mN1 ANK 1-7, whereas mN4 ANK 1-7 displayed no activity (Fig. 1D) , suggesting that unlike Notch 1, 2, and 3, Notch 4 is not hydroxylated by FIH-1.
A kinetic analysis of mN1 ANK 1-7 hydroxylation by FIH-1 demonstrated that the apparent V max is Ϸ7-fold lower than the apparent V max with the HIF-CAD substrate (Fig. 1E) . The apparent K m for mN1 ANK 1-7 is obviously at least an order of magnitude lower than the K m for HIF-CAD, although it could not be exactly determined because of limitations with the sensitivity of this assay. In vitro pulldown experiments demonstrated that FIH-1 interacted with purified mN1 ANK 1-7 with much higher affinity than with purified HIF-CAD (SI Fig. 7B ), supporting the results from the kinetic assay. In summary, the data reveal that Notch ICD is a substrate for FIH-1 hydroxylation and that the two hydroxylated Asn residues are located at positions similar to those found in other recently discovered ankyrin repeat-containing proteins hydroxylated by FIH-1 (10) . (Fig. 2 A) . Western blot analysis showed comparable expression levels for the wild type and Notch mutants (data not shown). Although the mutants showed significantly reduced activity, their functionality could partially be rescued by coexpression of the coactivator MAML1 (Fig. 2B ), indicating that the interaction with this coactivator is preserved in the mutated forms. In conclusion, mutation of the two Asn residues identified as targets of hydroxylation by FIH-1 substantially reduces the transactivation capacity of Notch ICD.
Mutation of Notch ICD N 1945 and N 2012 Residues Compromises Notch
Function in Neurogenesis and Myogenesis. In vertebrates, Notch signaling inhibits neuronal differentiation by promoting the maintenance of the progenitor state or glial differentiation (11) .
To explore the role of residues N 1945 and N 2012 in the control of neuronal differentiation, we introduced wild-type or mutated Notch ICD forms into the developing chick CNS by in ovo electroporation (Fig. 2C) , and we examined their effects on motor neuron generation as a readout of neurogenesis (SI Fig.  9 ). Wild-type Notch 1 ICD significantly blocked motor neuron differentiation, i.e., the number of cells expressing the motor neuron-specific transcription factor Isl1/2 was reduced by 80% (Fig. 2E ). Very few Notch 1 ICD-expressing cells coexpressed Isl1/2, whereas, in contrast, Notch 1 ICD colocalized extensively with the progenitor marker Sox3 (Fig. 2 D and F) . In the case of the N1945A and N1945A/N2012A mutants, we noted that the reduction in the number of cells expressing Isl1/2 was progressively smaller (47% and 21%, respectively) compared with wild-type Notch 1 ICD. Furthermore, fewer N1945A-and N1945A/N2012A-expressing cells colabeled with Sox3 compared with wild-type Notch 1 ICD and began to coexpress Isl1/2 ( Fig. 2  D and F) .
We next tested the effect of mutating N 1945 in the control of myogenic differentiation. To this end, we used the myogenic cell line C2C12, which can be induced to differentiate from a myoblast-like stage to form multinucleated myotubes after serum differentiation, and Notch signaling can abrogate this differentiation process (12, 13) . Transfection of Notch 1 ICD-GFP led to a reduced number of C2C12 cells expressing myosin heavy chain (MHC) compared with GFP expression alone. Expression of Notch 1 ICD N1945A-GFP led to a much more modest reduction in the number of differentiated, MHC-positive cells compared with wild-type Notch 1 ICD-GFP (Fig. 3A) . In conclusion, our results indicate that the function of Notch in repressing neuronal and myogenic differentiation is compromised when the critical Asn residues are mutated, consistent with the reduced transactivation function of the mutants.
FIH-1 Negatively Regulates Notch ICD and Accelerates Myogenic
Differentiation. We have observed that wild-type FIH-1 negatively regulates transactivation by Notch ICD (6) . To explore the functional significance of FIH-1 for Notch signaling in myogenic differentiation, yellow fluorescent protein (YFP)-tagged FIH-1 was transiently expressed in C2C12 cells cultured under differentiationpromoting conditions. Four days after transfection of FIH-1-YFP we observed an increased proportion of YFP-expressing cells coexpressing MHC compared with transfection of YFP alone. Interestingly, a similar increase in the proportion of differentiated C2C12 cells was observed also after transfection of the catalytically inactive H199A or D201A forms of FIH-1 (Fig. 3 B and C) . In conclusion, our data suggest that both wild-type and mutant FIH-1 can accelerate myogenic differentiation, consistent with negative regulation of Notch ICD function independent of hydroxylation and consistent with the very high affinity observed between Notch ICD and FIH-1.
To study this mode of regulation further, we transfected wild-type, H199A, and D201A FIH-1 together with Asn mutant Notch 1 ICD in 293T cells. Wild-type FIH-1, and FIH-1 H199A and D201A reduced the activity of CSL-dependent reporter activity driven by N1945A and N1945A/N2012A Notch 1 ICD (SI Fig. 7 C and D) , suggesting that the enzymatic activity is dispensable for negative regulation of Notch. However, in vitro pulldown assays demonstrated that FIH-1 interacts with nonhydroxylated Notch 1 ANK 1-7 with a much higher affinity than when it is hydroxylated (SI Fig. 7E ). Hence, hydroxylation may indirectly modulate negative regulation of the ICD by reducing affinity for FIH-1.
To assess the interaction between Notch ICD and FIH-1 in vivo, we studied whether Notch ICD could influence the intracellular localization of FIH-1. Expression of YFP-tagged FIH-1 revealed a predominantly cytoplasmic distribution. In contrast, coexpression of Notch 1 ICD with YFP-tagged FIH-1 changed the localization of FIH-1 to the nucleus in 64% of the fluorescent cells (Fig. 4A) . Expression of Notch ICD N1945A/N2012A also recruited FIH-1 to the nucleus, although to a lesser extent. A similar Notch ICD-dependent shift in intracellular localization of FIH-1 was observed in the chick neural tube after coelectroporation of FIH-1 with Notch 1 ICD. Wild-type Notch ICD resulted in nuclear localization of FIH-1, whereas Notch ICD N1945A/N2012A produced an intermediary distribution pattern (Fig. 4B) . These data support the notion that Notch ICD and FIH-1 interact in vivo but may also suggest that Asn mutant forms of Notch bind FIH-1 less effectively in vivo, given the more partial nuclear translocation of FIH-1 by Notch Asn mutants.
To examine the effect on Notch signaling by reducing endogenous FIH-1 levels, we transiently transfected a cell line stably expressing full-length Notch 1 with siRNAs targeting FIH-1 (Fig.  4C) . Notch function was activated by using immobilized Notch ligand (Jagged). A modest but significant (30%) increase in CSL-reporter gene activity was observed in cells transfected with FIH-1-specific siRNA under normoxic conditions (Fig. 4D) . Under hypoxic conditions, this difference was not evident. As a control for the efficacy of FIH-1 siRNA, inhibition of FIH-1 expression led to a dramatic increase of HIF-1-dependent activity at normoxia (Fig. 4E) . C2C12 cells stably expressing full-length Notch 1 were cocultured with cells stably expressing the Notch ligand Jagged-1. Ligand-dependent activation of Notch signaling under hypoxic conditions led to an increased recruitment of HIF-1␣ to the HRE-containing regions of the GLUT1, EPO, and VEGF promoters, whereas recruitment of Notch 1 ICD to the same promoter regions could not be detected (Fig. 5A) . These results extend our previous observations on the HIF-1␣ target gene PGK1 (6) and indicate that Notch-mediated potentiation of HIF-1␣ recruitment is a mechanism common to many, if not all, HIF-1␣ target genes.
We next investigated whether increased HRE binding of HIF-1␣ had any effect on HIF-1␣ target gene expression. To address this question, we analyzed by quantitative RT-PCR RNA from 293T cells stably expressing full-length Notch 1 in the presence or absence of Notch-specific ligand under normoxic or hypoxic conditions. As a reference, mRNA expression of the immediate Notch target gene Hey2 was up-regulated in cells treated with the Notch ligand Jagged, paralleled by activation of the HIF-1␣ target gene GLUT1, where mRNA expression increased to levels comparable with the hypoxic induction response (Fig. 5B) . Under hypoxic conditions, exposure to Notch ligand further enhanced the induction response, correlating with increased recruitment of HIF-1␣ to the GLUT1 promoter. These observations argue that activation of Notch pathway results in enhanced HIF-1␣ target gene mRNA expression.
Notch ICD-Mediated Derepression of HIF-1␣ Function Is Abrogated by
Elevated Levels of FIH-1. The fact that Notch-mediated increased recruitment of HIF-1␣ to the HRE of canonical hypoxiaactivated genes occurs without apparent recruitment of Notch ICD (Fig. 5A) suggests that Notch exerts its effect to derepress HIF-1␣ in a more indirect manner, with no apparent association with the active transcriptional complex. Given the high affinity of FIH-1 for Notch 1 ICD compared with HIF-1␣, it may be hypothesized that Notch ICD could act as a molecular ''sink'' and recruit FIH-1 away from HIF-1␣, resulting in transcriptional derepression of HIF1␣-dependent promoters. To test this hypothesis and to monitor the activity of only the portion of HIF-1␣ that is the target of FIH-1 activity, i.e., the CAD (5), we transiently transfected P19 cells with an expression vector encoding GAL4-fused HIF-1␣ CAD in the presence of increasing amounts of wild-type and Asn mutant Notch ICD expression vectors. Expression of wild-type Notch ICD resulted in a dosedependent increase in CAD-mediated activity at normoxia, as determined by a GAL4-driven reporter gene, whereas the Asn single and double mutants expressed at similar levels (data not shown) had very modest effects (Fig. 5C ). At hypoxia, no significant effect was observed in the presence of either wildtype or mutant Notch proteins (data not shown). We next observed that overexpression of FIH-1 abrogated Notch ICDdependent activation of HIF-1␣ CAD function at normoxia (Fig.  5D) . The catalytically inactive FIH-1 mutants D201A and H199A were partially or completely unable to restore inhibition of HIF-1␣ CAD activity in the presence of overexpressed Notch 1 ICD, consistent with the critical role of hydroxylation of N 803 for inhibition of CAD function (5). Our results indicate that Notch may enhance HIF-1␣ function by competing away FIH-1 from HIF-1␣ CAD and that repression of HIF-1␣ CAD at normoxia requires the full catalytic function of FIH-1. Why the Asn mutant Notch ICDs were less effective cannot be fully explained but may reflect the reduced interaction with FIH-1 under in vivo conditions where they are less effective than the wild-type protein at inducing nuclear localization of FIH-1 (Fig. 4A) .
Conclusions
Notch signaling and the cellular hypoxic response have recently been shown to be functionally integrated (6) . In this work, we reveal an additional layer of complexity in the cross-coupling of the two signaling pathways, involving the FIH-1 protein. (14) .
The two sites of hydroxylation, N 1945 and N 2012 , are located at similar positions before the ␤-hairpin turns separating ICD ANK 2 and 3 repeats, and 4 and 5 repeats, respectively (SI Fig. 10 ). Within these domains lie the primary contacts mediating formation of dimeric Notch complexes that are cooperatively formed on promoters with paired CSL-binding sites (15) . Importantly, it was observed that mutations that disrupt the predicted dimerization still allow monomeric ICD to form ternary complexes with MAML1 (15) . In our experiments, the transcriptional activity of Notch 1 ICD is severely impaired by mutations of one or both of the Asn residues but is restored in the presence of MAML1. It will therefore be important to investigate the role of the Asn residues in formation of higherorder ICD complexes. The two Asn residues are highly conserved among Notch paralogs and in different species, with the exception of Notch 4, which escapes Asn hydroxylation and FIH-1 interaction. This finding is, to our knowledge, a unique differential enzymatic modification in the Notch receptor family, and it will be interesting to learn whether it contributes to functional differences between different Notch receptors.
The present data show that FIH-1 also plays a role in how Notch potentiates the cellular hypoxic response. We observed that Notch 1 ICD-mediated derepression of HIF-1␣ was abrogated by increasing the level of FIH-1. Given that FIH-1 has higher affinity for Notch 1 ICD than for HIF-1␣, it is an interesting idea that Notch ICD can sequester FIH-1 away from HIF-1␣, resulting in derepression of HIF-1␣ function (SI Fig.  11 ). This mode of regulation occurred only if FIH-1 was present in limiting amounts, but not under conditions of excess FIH-1. To rerepress HIF-1␣, normoxic conditions were necessary, consistent with the requirement of the oxygen-dependent catalytic function of FIH-1. This mechanism may therefore be particularly relevant in situations where HIF-1␣ is stabilized under normoxic conditions, for example, in the von Hippel-Lindau syndrome (16) . In summary, the data on the role of FIH-1 in regulating Notch signaling reveals a more dynamic and complex relationship between Notch and hypoxia, suggesting that a fine-tuned control of signaling outputs from the two mechanisms is required for modulating the cellular response to low oxygen.
Materials and Methods
Details for the generation of plasmid constructs; the expression, purification, and MS analyses of Notch ICD functional domains; cell culture and transient transfection conditions; chick in ovo electroporation and immunohistochemistry; immunoblotting; intracellular localization; RNA interference; ChIP; and quantitative RT-PCR assays are given in SI Materials and Methods. 
